Association of Disease-Specific Health Status With Long-Term Survival in Peripheral Artery Disease.

Files

hdl_146216.pdf (853.44 KB)
  (Published version)

Date

2022

Authors

Tran, A.T.
Spertus, J.A.
Mena-Hurtado, C.I.
Jones, P.G.
Aronow, H.D.
Safley, D.M.
Malik, A.O.
Peri-Okonny, P.A.
Shishehbor, M.H.
Labrosciano, C.

Editors

Advisors

Journal Title

Journal ISSN

Volume Title

Type:

Journal article

Citation

Journal of the American Heart Association, 2022; 10(4):e022232-1-e022232-13

Statement of Responsibility

Andy T. Tran, John A. Spertus, Carlos I. Mena-Hurtado, Philip G. Jones, Herbert D. Aronow, David M. Safley, Ali O. Malik, Poghni A. Peri-Okonny, Mehdi H. Shishehbor, Clementine Labrosciano, Kim G. Smolderen

Conference Name

Abstract

Background: While peripheral artery disease (PAD) is associated with increased cardiovascular morbidity with mortality remaining high and challenging to predict, accurate understanding of serial PAD-specific health status around the time of diagnosis may prognosticate long-term mortality risk. Methods and Results: Patients with new or worsening PAD symptoms enrolled in the PORTRAIT Registry across 10 US sites from 2011 to 2015 were included. Health status was assessed by the Peripheral Artery Questionnaire (PAQ) Summary score at baseline, 3-month, and change from baseline to 3-month follow-up. Kaplan-Meier using 3-month landmark and hierarchical Cox regression models were constructed to assess the association of the PAQ with 5-year all-cause mortality. Of the 711 patients (mean age 68.8±9.6 years, 40.9% female, 72.7% white; mean PAQ 47.5±22.0 and 65.9±25.0 at baseline and 3-month, respectively), 141 (19.8%) died over a median follow-up of 4.1 years. In unadjusted models, baseline (HR, 0.90 per-10- point increment; 95% CI, 0.84–0.97; P=0.008), 3-month (HR [95% CI], 0.87 [0.82–0.93]; P<0.001) and change in PAQ (HR [95% CI], 0.92 [0.85–0.99]; P=0.021) were each associated with mortality. In fully adjusted models including combination of scores, 3-month PAQ was more strongly associated with mortality than either baseline (3-month HR [95% CI], 0.85 [0.78–0.92]; P<0.001; C-statistic, 0.77) or change (3-month HR [95% CI], 0.79 [0.72–0.87]; P<0.001). Conclusions: PAD-specific health status is independently associated with 5-year survival in patients with new or worsening PAD symptoms, with the most recent assessment being most prognostic. Future work is needed to better understand how this information can be used proactively to optimize care.

School/Discipline

Dissertation Note

Provenance

Description

Access Status

Rights

© 2022 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial- NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

License

Grant ID

Call number

Persistent link to this record